Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Euronext Bruxelles  >  UCB    UCB   BE0003739530

My previous session
Most popular
Delayed Quote. Delayed  - 08/17 05:36:05 pm
77.92 EUR   +0.31%
08/17UCB : Transparency notification BlackRock, Inc
08/16UCB : Transparency notification BlackRock, Inc.
08/16UCB : Threshold crossings
Analysis summaryMarketScreener Strategies

Jordan Dufee

share with twitter share with LinkedIn share with facebook
share via e-mail

After the accumulation, an upward acceleration ?

Strategy published on 10/06/2017 | 09:34
long trade
Target price hit
Entry price : 60.47€ | Target : 66€ | Stop-loss : 58€ | Potential : 9.15%
From a horizontal accumulation phase, the timing seems good to buy shares in UCB and to get ahead of a break-out on the upside of the congestion area.
Investors have an opportunity to buy the stock and target the € 66.
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
  • In a short-term perspective, the company has interesting fundamentals.

  • The share is getting closer to its long-term support in weekly data, at EUR 56.5, which offers good timing for buyers.
  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • The company is in a robust financial situation considering its net cash and margin position.

  • According to forecast, a sluggish sales growth is expected for the next fiscal years.
share with twitter share with LinkedIn share with facebook
share via e-mail

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials (€)
Sales 2018 4 564 M
EBIT 2018 1 122 M
Net income 2018 764 M
Finance 2018 75,5 M
Yield 2018 1,61%
P/E ratio 2018 19,09
P/E ratio 2019 17,61
EV / Sales 2018 3,30x
EV / Sales 2019 3,07x
Capitalization 15 156 M
Surperformance© ratings
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Earnings quality
Business Predictability
P/E ratio
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
Bollinger Spread
Unusual Volumes
Chart UCB
Duration : Period : Day
UCB Technical Analysis Chart | MarketScreener
Duration : Period : Week
UCB Technical Analysis Chart | MarketScreener